BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2017

Dec 5, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2017-11-30

Reporting Person: Davis George Eric (EVP, General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-11-30	Common Stock	S	1200	$85.639	Disposed	82942	Direct

Footnotes

F1: All shares sold at the same price.

F2: Amount of securities beneficially owned has been updated from the reporting person's prior report to: a) include 804 shares reported in the Form 4 Amendment filed with the S.E.C. on 10/13/2017; and b) exclude 243 shares inadvertently included in prior reports based on a reconciliation with the Company's records.